Literature DB >> 3608343

Circadian changes in the pharmacokinetics of oral ketoprofen.

M Ollagnier, H Decousus, Y Cherrah, F Levi, M Mechkouri, P Queneau, A Reinberg.   

Abstract

Several investigations which have taken treatment time into account have shown that the pharmacokinetic parameters, the therapeutic efficacy and even the toxicity of a large number of products may vary according to the administration schedule. The present study was carried out in order to evaluate any circadian changes in pharmacokinetic parameters of ketoprofen, a new non-steroidal anti-inflammatory drug (NSAID). This randomised crossover study consisted of a single oral dose of ketoprofen 100mg administered to 8 healthy male volunteers, mean age 27.2 years, at 07.00 hours, 13.00 hours, 19.00 hours or 01.00 hours in 4 study periods during the first 3 months of the year. The order of administration was randomised, with each subject acting as his own control. A total of 14 blood and 4 urine samples were taken over a 12-hour period. The peak plasma concentration was twice as high after drug administration at 07.00 hours (13.4 +/- 1 mg/L) than after other administration times (13.00 hours: 6.9 +/- 1; 19.00 hours: 7.2 +/- 0.7; 01.00 hours: 6.3 +/- 0.5 mg/L) [p less than 0.001]. The time to reach peak concentration was much longer after drug administration at 01.00 hours (135 +/- 16.7 min) than at 07.00 (73.1 +/- 14.1 min), 13.00 (75 +/- 16.5 min) or 19.00 hours (82.5 +/- 12.7 min) [p less than 0.05]. The lag time was significantly longer at 01.00 hours than at 13.00 hours (p less than 0.01). The absorption rate constant after treatment at 01.00 hours was less than at the other times of administration (p less than 0.05). The bodyweight-corrected area under the curve (AUC0-12) was greater after 07.00 hours than after 13.00 (p less than 0.01) or 19.00 hours (p less than 0.05) and greater after 01.00 hours than after 13.00 hours (p less than 0.05). The elimination half-life was significantly longer after administration at 01.00 hours than after 19.00 hours (p less than 0.05), while the total clearance was lowest at 07.00 hours. Cosinor analysis demonstrated statistically significant circadian rhythms for all pharmacokinetic parameters described above. The amount of ketoprofen eliminated in the urine was delayed, and was significantly greater after the administration at 01.00 hours than 07.00 hours or 19.00 hours (p less than 0.01). The relationship between absorption, diffusion and/or elimination mechanisms of the drug are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3608343     DOI: 10.2165/00003088-198712050-00003

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  48 in total

1.  RHYTHMIC URINARY EXCRETION OF AMPHETAMINE IN MAN.

Authors:  A H BECKETT; M ROWLAND
Journal:  Nature       Date:  1964-12-19       Impact factor: 49.962

2.  Circadian study on serum gastrin in patients with duodenal ulcers and in a control group.

Authors:  B Tarquini; A Brocchi; L Buricchi; G Cappelli; A Costa; B Neri; M Cagnoni
Journal:  Chronobiologia       Date:  1977 Jan-Mar

3.  [Biological behavior: serum levels, excretion and biotransformation of (3-benzoylphenyl)-2-propionic acid, or ketoprofen, in animals and men].

Authors:  P Populaire; B Terlain; S Pascal; B Decouvelaere; A Renard; J P Thomas
Journal:  Ann Pharm Fr       Date:  1973-12

4.  Time dependent changes in the pharmacokinetics of aspirin.

Authors:  A Markiewicz; K Semenowicz
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-10

5.  [Circadian rhythms in the urinary excretion of salicylate (chronopharmacokinetics) in healthy adults].

Authors:  A Reinberg; J Clench; J Ghata; F Halberg; C Abulker; J Dupont; Z Zagula-Mally
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1975-04-14

6.  Gastrointestinal transit: the effect of the menstrual cycle.

Authors:  A Wald; D H Van Thiel; L Hoechstetter; J S Gavaler; K M Egler; R Verm; L Scott; R Lester
Journal:  Gastroenterology       Date:  1981-06       Impact factor: 22.682

7.  The effect of timing of a single injection on the toxicity of methotrexate in the rat.

Authors:  J English; G W Aherne; V Marks
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Circadian rhythms of urinary excretions of water and electrolytes in patients receiving total parenteral nutrition (TPN).

Authors:  H Muratani; T Kawasaki; M Ueno; N Kawazoe; M Fujishima
Journal:  Life Sci       Date:  1985-08-19       Impact factor: 5.037

9.  The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study.

Authors:  N Baber; L Halliday; R Sibeon; T Littler; M L Orme
Journal:  Clin Pharmacol Ther       Date:  1978-09       Impact factor: 6.875

10.  Circadian serum gastrin concentrations in control persons and in patients with ulcer disease.

Authors:  G Feurle; H Ketterer; H D Becker; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

View more
  12 in total

Review 1.  Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Authors:  N M Davies; N M Skjodt
Journal:  Clin Pharmacokinet       Date:  2000-05       Impact factor: 6.447

2.  Circadian variation in urinary excretion of ciprofloxacin after a single-dose oral administration at 1000 and 2200 hours in human subjects.

Authors:  V V Rao; D Rambhau; B R Rao; P Srinivasu
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  The relative bioavailability of diclofenac with respect to time of administration.

Authors:  M Mustofa; S Suryawati; I Dwiprahasto; B Santoso
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

Review 4.  Chronopharmacokinetics. Current status.

Authors:  B Bruguerolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics 1990.

Authors:  G R Matzke; W L St Peter
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 6.  Circadian rhythms have broad implications for understanding brain and behavior.

Authors:  Rae Silver; Lance J Kriegsfeld
Journal:  Eur J Neurosci       Date:  2014-05-05       Impact factor: 3.386

7.  Modelling circadian variation in the pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  J K Aronson; M J Chappell; K R Godfrey; M K Yew
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 8.  Clinical pharmacokinetics of ketoprofen and its enantiomers.

Authors:  F Jamali; D R Brocks
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 9.  Pharmacokinetic optimisation of the treatment of osteoarthritis.

Authors:  K J Skeith; D R Brocks
Journal:  Clin Pharmacokinet       Date:  1994-03       Impact factor: 6.447

10.  Single and multiple dose pharmacokinetics of enteric coated ketoprofen: effect of cimetidine.

Authors:  R K Verbeeck; C L Corman; S M Wallace; R J Herman; S G Ross; P Le Morvan
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.